Trial Outcomes & Findings for Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa (NCT NCT03977818)

NCT ID: NCT03977818

Last Updated: 2025-09-05

Results Overview

TNT: time from the systemic treatment onset to the next treatment or death due to any cause, whichever came first. OS: time from the systemic treatment onset to death

• Recruitment status: COMPLETED
• Target enrollment: 2165 participants
• Primary outcome timeframe: 2 years
• Results posted on: 2025-09-05

Participant Flow

Participant milestones

Measure	Patients With Metastatic Softtissue Sarcomas Diagnosed Between 1990 and 2013 Patients with metastatic softtissue sarcomas diagnosed between 1990 and 2013 and satisfying all eligibility criteria
Overall Study STARTED	2165
Overall Study COMPLETED	2165
Overall Study NOT COMPLETED	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Patterns of Care and Outcomes in METAstatic Soft Tissue SARComa

Baseline characteristics by cohort

Measure	Patients With Metastatic Softtissue Sarcomas Diagnosed Between 1990 and 2013 n=2165 Participants Patients with metastatic softtissue sarcomas diagnosed between 1990 and 2013 and satisfying all eligibility criteria
Age, Customized Age · < 75 years	1886 Participants n=5 Participants
Age, Customized Age · >= 75 years	279 Participants n=5 Participants
Sex: Female, Male Female	1110 Participants n=5 Participants
Sex: Female, Male Male	1055 Participants n=5 Participants
Region of Enrollment France	2165 participants n=5 Participants

PRIMARY outcome

Timeframe: 2 years

Population: Patients with metastatic softtissue sarcomas diagnosed between 1990 and 2013 and satisfying all eligibility criteria

TNT: time from the systemic treatment onset to the next treatment or death due to any cause, whichever came first.

OS: time from the systemic treatment onset to death

Outcome measures

Measure	Patients With Metastatic Softtissue Sarcomas Diagnosed Between 1990 and 2013 n=2165 Participants Patients with metastatic softtissue sarcomas diagnosed between 1990 and 2013 and satisfying all eligibility criteria
Correlation Between Time to Next Treatment (TNT) and Overall Survival (OS) Under First-line Treatment	0.76 correlation coefficient Interval 0.73 to 0.78

Adverse Events

Patients With Metastatic Softtissue Sarcomas Diagnosed Between 1990 and 2013

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Pr Antoine Italiano

Institut Bergonié

Phone: 33 5 56 33 33 33

Email: a.italiano@bordeaux.unicancer.fr

Results disclosure agreements

• Principal investigator is a sponsor employee
• Publication restrictions are in place